查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1892084

2025-2030年针对心理和情绪健康的功能性成分市场成长机会

Growth Opportunities in Functional Ingredients Targeting Mental and Emotional Well-Being, 2025-2030
出版日期: | 出版商: Frost & Sullivan | 英文 52 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

推动心理和情绪健康未来发展的创新策略

本研究深入检验了旨在改善心理和情绪健康的新型功能性成分，并对2030年前的成长要素、技术创新和市场机会进行了全面分析。精神疾病仍然是一项重大的全球性挑战，焦虑症和忧郁症影响着全球超过10亿人。这表明人们对有效、按需且可常规获得的干预措施的需求日益增长。目前，药物治疗方法、数位疗法和新型人工智慧驱动的个人化护理模式正在不断创新，天然植物疗法和补充剂也正进入市场以填补治疗空白。小分子药物、注射、数位治疗和监测工具以及促智製剂的整合正在推动心理健康和情绪健康治疗领域的成长和创新。企业和雇主对员工心理健康的投入，以及不断变化的监管要求，正在推动市场机会。儘管劳动力、社会污名和就医途径方面仍然存在挑战，但精准精神病学以及技术驱动的、基于人工智慧的心理健康诊断和监测预示着未来治疗效果的改善。最后，该报告检验了竞争格局、资金筹措、伙伴关係和新疗法，为对不断发展的心理健康和情绪健康领域感兴趣的相关人员提供了有用的指导。

目录

策略要务

  • 为什么经济成长变得越来越困难？
  • The Strategic Imperative 8
  • 三大策略要务对针对心理和情绪健康的活性成分的影响
  • 成长引擎由成长机会驱动
  • 调查方法

成长机会分析

  • 分析范围
  • 分割

成长驱动因素

  • 成长要素
  • 成长限制因素

心理健康和情绪健康的新兴疗法

  • 心理健康与情绪福祉：现况与挑战
  • 心理健康和情绪健康的影响
  • 心理健康照护策略
  • 加速心理健康心理治疗
  • 加速在精神健康领域使用小分子药物、注射剂和舌下膜剂
  • 加速利用数位工具、人工智慧和虚拟实境技术促进心理健康
  • 加速心理健康远端医疗
  • 加速益智药对心理健康的益处
  • 欧洲和美国当前的心理健康状况
  • 亚太和中东地区的心理健康状况
  • 心理健康产业发展面临的挑战

创新现况：心理健康与情绪健康临床研发管线概述

  • 药物介入对心理健康的影响
  • 药物介入促进心理健康—创新者简介

资金筹措、合作关係和收购

  • 资金筹措分析
  • 重要合作伙伴关係和收购

前景

  • 个人化情绪调节成分－视角
  • 生物活性植物化合物与适应原在压力管理的兴起－一个视角
  • 拓展功能性营养品市场，提升心理健康益处－展望

心理和情绪健康方面的成长机会领域

  • 成长机会 1：处方数位疗法 (PDT)
  • 成长机会2：企业对心理健康领域的投资
  • 成长机会 3：扩展与个人化自我护理生态系统

未来发展

  • 成长机会带来的益处和影响
  • 未来计划
  • 免责声明
简介目录
Product Code: DB4E

Innovative Strategies Driving the Future of Mental and Emotional Well-Being

The study presents an in-depth exploration of novel functional ingredients designed to enhance mental and emotional well-being, identifying the overall drivers of growth, technological change, and market opportunities through 2030. Mental health disorders continue to present a serious global challenge, with anxiety and depression affecting more than 1 billion individuals worldwide. This indicates only intensifying demand for interventions that are both effective and can be employed on demand and routinely. Innovation is now occurring in pharmacological therapies, digital therapeutics, new AI-driven personalized care models, and natural botanical therapies and supplements are entering the marketplace to address therapy gaps. The incorporation of small molecules, injectables, digital therapeutics and monitoring tools, and nootropic formulations is driving growth and innovation in the treatment of mental health and emotional well-being. Corporate- and employer-branded investments in employee mental well-being, along with changing regulatory requirements, will contribute to the market opportunity. While some challenges remain related to workforce, stigma, and access, precision psychiatry and technology-driven AI-based mental health diagnostics and monitoring can indicate better future outcomes. Lastly, the report will examine the competitive landscape, funding, partnerships, and new therapies to provide useful directions for stakeholders interested in the expanding mental health and emotional well-being space.

Table of Contents

Strategic Imperatives

  • Why Is It Increasingly Difficult to Grow?
  • The Strategic Imperative 8
  • The Impact of the Top 3 Strategic Imperatives on Functional Ingredients Targeting Mental and Emotional Well-Being
  • Growth Opportunities Fuel the Growth Pipeline Engine
  • Research Methodology

Growth Opportunity Analysis

  • Scope of Analysis
  • Segmentation

Growth Generator

  • Growth Drivers
  • Growth Restraints

Emerging Therapies to Address Mental Health and Emotional Well-Being

  • Mental Health and Emotional Well-Being: Facts and Challenges
  • Impact of Mental Health and Emotional Well-Being
  • Mental Health Care Strategies
  • Accelerating Psychotherapies for Mental Health
  • Accelerating Small Molecule/Injectables/Sublingual Films for Mental Health
  • Accelerating Digital Tools/AI/VR for Mental Health
  • Accelerating Telemedicine for Mental Health
  • Accelerating Nootropics for Mental Health
  • The Mental Health Landscape in Europe and the United States
  • The Mental Health Landscape in APAC and the Middle East
  • Challenges in Advancing the Mental Health Industry

Innovation Landscape: Clinical Pipeline Overview for Mental Health and Emotional Well-Being

  • Pharmacological Interventions for Mental Well-Being
  • Pharmacological Interventions for Mental Well-Being-Innovator Profiles

Funding, Partnerships, and Acquisitions

  • Funding Analysis
  • Key Partnerships and Acquisitions

Outlook

  • Personalized Formulation of Mood-Enhancing Ingredients-Outlook
  • Rise of Bioactive Botanicals and Adaptogens for Stress-Outlook
  • Growing Market for Functional Nutrition with Mental Health Benefits-Outlook

Growth Opportunity Universe for Mental and Emotional Well-Being

  • Growth Opportunity 1: Prescription Digital Therapeutics PDTs
  • Growth Opportunity 2: Corporate Mental Health Investment
  • Growth Opportunity 3: Expansion and Personalization of Self-Care Ecosystems

Next Steps

  • Benefits and Impacts of Growth Opportunities
  • Next Steps
  • Legal Disclaimer